Enliven Therapeutics, Inc.

NASDAQ:ELVN

Biotechnology

Healthcare
$44.89 -0.27%

-$0.12 today

Market cap
$3.30B
Beta
0.40
P/E (TTM)
-28.4
EPS (TTM)
-$1.57
52W Low $14.79High $48.53

Volume 0.75M

Average 1.35M

News

For Enliven Therapeutics, Inc., read summarized stories built from several publishers and recent headlines with links to the original coverage.

No stories for ELVN yet. A story appears once at least three publishers cover the same event.